These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31029764)

  • 1. Melatonin MT
    Comai S; Lopez-Canul M; De Gregorio D; Posner A; Ettaoussi M; Guarnieri FC; Gobbi G
    Pharmacol Res; 2019 Jun; 144():343-356. PubMed ID: 31029764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.
    Liu J; Clough SJ; Hutchinson AJ; Adamah-Biassi EB; Popovska-Gorevski M; Dubocovich ML
    Annu Rev Pharmacol Toxicol; 2016; 56():361-83. PubMed ID: 26514204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual discovery of melatonin receptor ligands to modulate circadian rhythms.
    Stein RM; Kang HJ; McCorvy JD; Glatfelter GC; Jones AJ; Che T; Slocum S; Huang XP; Savych O; Moroz YS; Stauch B; Johansson LC; Cherezov V; Kenakin T; Irwin JJ; Shoichet BK; Roth BL; Dubocovich ML
    Nature; 2020 Mar; 579(7800):609-614. PubMed ID: 32040955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin MT
    López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression.
    Wu YH; Ursinus J; Zhou JN; Scheer FA; Ai-Min B; Jockers R; van Heerikhuize J; Swaab DF
    J Affect Disord; 2013 Jun; 148(2-3):357-67. PubMed ID: 23357659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Function of Melatonin MT
    Gobbi G; Comai S
    Front Endocrinol (Lausanne); 2019; 10():87. PubMed ID: 30881340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep-wake characterization of double MT₁/MT₂ receptor knockout mice and comparison with MT₁ and MT₂ receptor knockout mice.
    Comai S; Ochoa-Sanchez R; Gobbi G
    Behav Brain Res; 2013 Apr; 243():231-8. PubMed ID: 23333399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology.
    Comai S; Gobbi G
    J Psychiatry Neurosci; 2014 Jan; 39(1):6-21. PubMed ID: 23971978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin receptors as therapeutic targets in the suprachiasmatic nucleus.
    Pévet P
    Expert Opin Ther Targets; 2016 Oct; 20(10):1209-18. PubMed ID: 27082492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression.
    Boiko DI; Shkodina AD; Hasan MM; Bardhan M; Kazmi SK; Chopra H; Bhutra P; Baig AA; Skrypnikov AM
    Neurochem Res; 2022 Oct; 47(10):2909-2924. PubMed ID: 35689787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MT1 and MT2 melatonin receptors are expressed in nonoverlapping neuronal populations.
    Klosen P; Lapmanee S; Schuster C; Guardiola B; Hicks D; Pevet P; Felder-Schmittbuhl MP
    J Pineal Res; 2019 Aug; 67(1):e12575. PubMed ID: 30937953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin receptors, brain functions, and therapies.
    Oishi A; Gbahou F; Jockers R
    Handb Clin Neurol; 2021; 179():345-356. PubMed ID: 34225974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain.
    Lacoste B; Angeloni D; Dominguez-Lopez S; Calderoni S; Mauro A; Fraschini F; Descarries L; Gobbi G
    J Pineal Res; 2015 May; 58(4):397-417. PubMed ID: 25726952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin, selective and non-selective MT1/MT2 receptors agonists: differential effects on the 24-h vigilance states.
    Ochoa-Sanchez R; Comai S; Spadoni G; Bedini A; Tarzia G; Gobbi G
    Neurosci Lett; 2014 Feb; 561():156-61. PubMed ID: 24406151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep well. Untangling the role of melatonin MT1 and MT2 receptors in sleep.
    Gobbi G; Comai S
    J Pineal Res; 2019 Apr; 66(3):e12544. PubMed ID: 30586215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
    Zlotos DP; Jockers R; Cecon E; Rivara S; Witt-Enderby PA
    J Med Chem; 2014 Apr; 57(8):3161-85. PubMed ID: 24228714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT
    Tchekalarova J; Kortenska L; Ivanova N; Atanasova M; Marinov P
    Psychopharmacology (Berl); 2020 Feb; 237(2):503-518. PubMed ID: 31720718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin receptors: role on sleep and circadian rhythm regulation.
    Dubocovich ML
    Sleep Med; 2007 Dec; 8 Suppl 3():34-42. PubMed ID: 18032103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melancholic-Like behaviors and circadian neurobiological abnormalities in melatonin MT1 receptor knockout mice.
    Comai S; Ochoa-Sanchez R; Dominguez-Lopez S; Bambico FR; Gobbi G
    Int J Neuropsychopharmacol; 2015 Jan; 18(3):. PubMed ID: 25638817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The location, physiology, pathology of hippocampus Melatonin MT
    Feng Y; Jiang X; Liu W; Lu H
    Eur J Med Chem; 2023 Dec; 262():115888. PubMed ID: 37866336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.